Close
Help
Need Help?





JOURNAL

Clinical Medicine Reviews in Oncology

105,784 Journal Article Views | Journal Analytics

Denosumab as Bone Modifying Therapy in Solid Tumors

Submit a Paper



Publication Date: 20 Oct 2011

Type: Review

Journal: Clinical Medicine Reviews in Oncology

Citation: Clinical Medicine Reviews in Oncology 2011:3 107-113

doi: 10.4137/CMRO.S6574

Abstract

For many solid tumors, bone is a common site of spread and one that compromises the quality of life of patients. The routine use of adjunctive intravenous bisphosphonates (IVBs) decreases skeletal related events such as fracture, hypercalcemia, spinal cord compression, and the need for palliative radiation therapy or orthopaedic stabilization. Denosumab has recently been approved as a bone modifying agent in oncology. This monoclonal antibody inhibits the receptor activator of nuclear factor kB ligand (RANKL), which mediates osteoclast differentiation, function and survival. In patient with bone metastases, Denosumab is at least equivalent to the IVBs. While the incidence of osteonecrosis of the jaw is similar to what has been reported with the IVBs, fever and pyrexia are not observed, and hypocalcemia and renal impairment are less frequent. We review the data leading to approval of denosumab as a bone-directed therapy in oncology and compare and contrast the efficacy and toxicity with intravenous bisphosphonates.


Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)




Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Clinical Medicine Reviews in Oncology
The process of submitting the paper was smooth with little time required on the author's behalf. Reviews were prompt and the process of addressing reviewer comments was very streamlined. All correspondence with the editorial office was extremely professional with immediate responses. This is one of the few journals asking for feedback on their submission process.
Dr Greg Trottier, MD, PhD, FRCSC (University of Toronto, Toronto, Ontario, Canada)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results